Concepedia

The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis

Madeline L Kelly, Arseniy Lavrov, Luis Garcia‐Gancedo, Jim Parr, Robert G. Hart, Theresa Chiwera, Christopher E. Shaw, Ammar Al‐Chalabi, Rachael Marsden, Martin R. Turner,

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2020 · 23 citations · 12 references

DOIFull text

Open access

Concepts

Abstract

OBJECTIVE: Biotelemetry measures of physical activity in this Pilot Study tracked ALS progression over time, highlighting their potential as endpoints for future clinical trials. A larger, formally powered study is required to further support activity endpoints as novel disease progression markers.

References

12

Calculating correlation coefficients with repeated observations: Part 2—correlation between subjects

J Martin Bland, Douglas G. Altman · BMJ · 1995 · 1.1K citations · Full text

, , +15

Statistics notes: Calculating correlation coefficients with repeated observations: Part 1—correlation within subjects

John M. Bland, Douglas G. Altman · BMJ · 1995 · 1K citations · Full text

, , +16

Predicting Early Bulbar Decline in Amyotrophic Lateral Sclerosis: A Speech Subsystem Approach

Panying Rong, Yana Yunusova, Jun Wang et al. · Behavioural Neurology · 2015 · 154 citations · Full text

, , +16

Profiling Speech and Pausing in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)

Yana Yunusova, Naida L. Graham, Sanjana Shellikeri et al. · PLoS ONE · 2016 · 114 citations · Full text

, , +17

Speech deterioration in amyotrophic lateral sclerosis (ALS) after manifestation of bulbar symptoms

Tanja Makkonen, Hanna Ruottinen, Riitta Puhto et al. · International Journal of Language & Communication Disorders · 2017 · 88 citations

, , +17